Yutaka Kuroda

Yutaka Kuroda

Auto-generated profile, based on publicly available information

Yutaka Kuroda

Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Bone & Joint Research
Verified
Journal Article
Open access
YKYutaka Kuroda
Yutaka Kuroda
TTTakeyuki Tanaka
Takeyuki Tanaka
TMTakaki Miyagawa
Takaki Miyagawa
Toshiyuki KawaiToshiyuki Kawai
Toshiyuki Kawai
KGKoji Goto
Koji Goto
HAHaruhiko Akiyama
Haruhiko Akiyama
Objectives: Using a simple classification method, we aimed to estimate the collapse rate due to osteonecrosis of the femoral head (ONFH) in order to develop treatment guidelines for joint-preserving surgeries. Methods: We retrospectively analyzed 505 hips from 310 patients (141 men, 169 women; mean age 45.5 years (sd 14.9; 15 to 86)) diagnosed with ONFH and classified them using the Japanese Investigation Committee (JIC) classification. The JIC system includes four visualized types based on the location and size of osteonecrotic lesions on weightbearing surfaces (types A, B, C1, and C2) and the stage of ONFH. The collapse rate due to ONFH was calculated using Kaplan–Meier survival analysis, with radiological collapse/arthroplasty as endpoints. Results: Bilateral cases accounted for 390 hips, while unilateral cases accounted for 115. According to the JIC types, 21 hips were type A, 34 were type B, 173 were type C1, and 277 were type C2. At initial diagnosis, 238/505 hips (47.0%) had already collapsed. Further, the cumulative survival rate was analyzed in 212 precollapsed hips, and the two-year and five-year collapse rates were found to be 0% and 0%, 7.9% and 7.9%, 23.2% and 36.6%, and 57.8% and 84.8% for types A, B, C1, and C2, respectively. Conclusion: Type A ONFH needs no further treatment, but precollapse type C2 ONFH warrants immediate treatment with joint-preserving surgery. Considering the high collapse rate, our study results justify the importance of early diagnosis and intervention in asymptomatic patients with type C2 ONFH. Cite this article: Y. Kuroda, T. Tanaka, T. Miyagawa, T. Kawai, K. Goto, S. Tanaka, S. Matsuda, H. Akiyama. Classification of osteonecrosis of the femoral head: Who should have surgery?. Bone Joint Res 2019;8:451–458. DOI: 10.1302/2046-3758.810.BJR-2019-0022.R1.

1 August 2017 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
HTH. Tateuchi
H. Tateuchi
YKY. Koyama
Y. Koyama
HAH. Akiyama
H. Akiyama
KGK. Goto
K. Goto
KSK. So
K. So
NIN. Ichihashi
N. Ichihashi

22 October 2019 in Inflammation and Regeneration
Verified
Journal Article
Open access
PDF file
YKYutaka Kuroda
Yutaka Kuroda
TKToshiyuki Kawai
Toshiyuki Kawai
KGKoji Goto
Koji Goto
SMShuichi Matsuda
Shuichi Matsuda
Bone regeneration has been the ultimate goal in the field of bone and joint medicine and has been evaluated through various basic research studies to date. Translational research of regenerative medicine has focused on three primary approaches, which are expected to increase in popularity: cell therapy, proteins, and artificial materials. Among these, the local injection of a gelatin hydrogel impregnated with the protein fibroblast growth factor (FGF)-2 is a biomaterial technique that has been developed in Japan. We have previously reported the efficacy of gelatin hydrogel containing injectable FGF-2 for the regenerative treatment of osteonecrosis of the femoral head. Injectable growth factors will probably be developed in the future and gain popularity as a medical approach in various fields as well as orthopedics. Several clinical trials have already been conducted and have focused on this technique, reporting its efficacy and safety. To date, reports of the clinical application of FGF-2 in revascularization for critical limb ischemia, treatment of periodontal disease, early bone union for lower limb fracture and knee osteotomy, and bone regeneration for osteonecrosis of the femoral head have been based on basic research conducted in Japan. In the present report, we present an extensive review of clinical applications using injectable growth factors and discuss the associated efficacy and safety of their administration.

1 September 2012 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
YFYoshihiro Fukumoto
Yoshihiro Fukumoto
TITome Ikezoe
Tome Ikezoe
HTHiroshige Tateuchi
Hiroshige Tateuchi
RTRui Tsukagoshi
Rui Tsukagoshi
HAHaruhiko Akiyama
Haruhiko Akiyama
NINoriaki Ichihashi
Noriaki Ichihashi

3 July 2013 in Clinical Rehabilitation
Verified
Journal Article
Closed access
YFYoshihiro Fukumoto
Yoshihiro Fukumoto
HTHiroshige Tateuchi
Hiroshige Tateuchi
TITome Ikezoe
Tome Ikezoe
RTRui Tsukagoshi
Rui Tsukagoshi
HAHaruhiko Akiyama
Haruhiko Akiyama
NINoriaki Ichihashi
Noriaki Ichihashi
Objective: To investigate the effects of high-velocity resistance training on muscle function, muscle properties, and physical performance in patients with hip osteoarthritis by comparison with those of low-velocity resistance training. Design: Single-blind randomized controlled trial. Setting: Home-based exercise programmes. Subjects: A total of 46 women with hip osteoarthritis were randomly assigned to the high-velocity ( n = 23) or low-velocity ( n = 23) training group. Interventions: Both groups underwent an eight-week daily home-based resistance training programme using an elastic band. Exercises involved hip abduction, extension, and flexion and knee extension. Participants in the high-velocity group performed the concentric phase of each repetition as rapidly as possible and returned to the initial position eccentrically in 3 s. Participants in the low-velocity group performed both the concentric and eccentric phases in 3 s. Main measures: The following outcome measures were evaluated: isometric muscle strength, muscle power, muscle thickness, muscle echo intensity, maximum walking speed, Timed Up and Go test, 3-minute walking test, Harris Hip Score, and hip pain. Results: Decreases in the time for performing the Timed Up and Go test (mean changes: high-velocity group −0.46 s, low-velocity group −0.23 s) and echo intensity of the gluteus maximus (mean changes: high-velocity group −6.8, low-velocity group −1.0) were significantly greater in the high-velocity group than in the low-velocity group. No significant difference was observed in changes of other outcome measures between the groups. Conclusion: This study revealed that high-velocity training for patients with hip osteoarthritis has partially a greater effect on muscle properties and physical performance than low-velocity training.

29 December 2015 in International Orthopaedics
Verified
Journal Article
Open access
PDF file
YKYutaka Kuroda
Yutaka Kuroda
RARyuta Asada
Ryuta Asada
KSKazutaka So
Kazutaka So
AYAtsushi Yonezawa
Atsushi Yonezawa
MNManabu Nankaku
Manabu Nankaku
HAHaruhiko Akiyama
Haruhiko Akiyama
We evaluated the safety and clinical outcomes of a single local administration of gelatin hydrogel impregnated with recombinant human fibroblast growth factor (rhFGF)-2 for the treatment of the precollapse stage of osteonecrosis of the femoral head (ONFH).